--- title: 'Director, Value, Access Strategy, and Payer Marketing (GOMEKLI) at SpringWorks Therapeutics' canonical: 'https://feeny.ai/job/director-value-access-strategy-and-payer-marketing-gomekli-springworks-2tywycqw7e6b' type: 'job' last_seen: '2026-09-13' --- # Director, Value, Access Strategy, and Payer Marketing (GOMEKLI) at SpringWorks Therapeutics - **Company:** SpringWorks Therapeutics - **Location:** /, United States - **Work type:** remote - **Posted:** 2026-08-06 - **Last confirmed live:** 2026-09-13 - **Apply:** https://springworkstx.com/careers/view-opportunities/?gh_jid=6136265004 ## Job description About SpringWorks Therapeutics: SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN). At SpringWorks, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for. Your Role: The Director, Value, Access Strategy, and Payer Marketing (VAP) GOMEKLI is a critical leadership role within the U.S. Market Access team, responsible for shaping the strategic direction and leading the development and execution of market access and pricing strategies to support the commercial success of GOMEKLI. This individual will lead the development of access strategies and tactics that communicate the differentiated value of GOMEKLI to key external stakeholders—including payers, C-suite executives, provider networks, GPOs, pharmacists, and population-based decision-makers in community oncology. The Director will be accountable for delivering a suite of payer and provider-facing tools, field team resources, and non-personal engagement tactics to ensure optimal access and uptake. The Director will collaborate closely with cross-functional partners including brand marketing, sales, HEOR, medical affairs, patient services, and operations to ensure strategic alignment and execution excellence.  This position reports to the Executive Director, Value, Access & Pricing – Rare Tumors and works in close partnership with the broader U.S. Market Access. This role is open for remote consideration​ #LI-Remote This role is preferred hybrid: work onsite 3 days a week at our Seaport office Essential Duties and Responsibilities: - Act as the product-specific market access expert and central hub for all access-related topics, serving as the primary point of contact for cross-functional teams and informing the broader U.S. Market Access organization on product-specific developments, strategies, and insights - Leads the development of Market Access strategies and evidence-based payor value proposition; manages the execution of brand aligned Market Access tactical plans that influence coverage decisions and remove patient access hurdles - Leads strategic and tactical development and pull through of various field-based resources to support field facing teams including Strategic Enterprise Account Directors (SEADs), Field Access Managers (FAMs), and Sales teams - Shapes the development of pricing and contracting strategies, ensuring market competitiveness, payor acceptance and coverage policies that enable patient access - Manage Pricing and Government Pricing annual lifecycle, including both strategic and operational activities to maintain compliance with regulations - Continuously evaluates changing market and competitive dynamics to inform short and long-term strategies including but not limited to formulary positioning, contracting, pricing, real-world evidence generation and public policy - Leads the management of key strategic partner relationships to ensure execution of the strategic vision and tactical goals as well as the timely completion of projects within budget - Monitor evolving reimbursement and policy landscape and integrate insights into access strategy - Measure and report impact of targeted launch / access tactical plan investments Role Requirements: Education: - Bachelor's degree (business or related disciplines) - MBA or other advanced degree preferred Skills/Experience: - 9+ years of pharmaceutical and/or biotech experience required in rare disease or Oncology - 5+ years in internal Market access role - Internal rare disease/oncology launch experience required (strategic, operational and tactical) - Inline rare disease/oncology product market access and cross-functional brand team experience required - Value/payer marketing and customer insights generation experience required - Field and/or field payer experience preferred - New Product Pricing experience preferred - Understanding of Oncology value frameworks, HeOR, pricing, policy and patient advocacy preferred - Experience in patient administered products (Part D, oral) - Experience working a collaborative, dynamic, accountable environment Technical: - Expert in US market access environment with knowledge of recent policy changes, external product launches and current dynamics in Rare & Oncology Other: - Collaborative and curious, with innovative drive and continuous improvement mindset - Ability to travel to market access internal and external customer-facing meetings 30-40% Leadership: - Inclusive, humble, people-first leader with demonstrated examples of successful collaboration and engagement in a fast-moving environment Communication: - Strong communication both written and verbal - Ability to influence up and across to achieve strategic objectives, gain alignment and secure resources Preferred Qualifications: - Ability to communicate openly and share information to foster trust while encouraging constructive debate, making informed decisions, and ensuring shared commitment to outcomes. - Demonstrated willingness to take risks and stand up for what is right while prioritizing the needs and experiences of customers and patients in all decisions. - Commitment to setting and reaching ambitious goals and setting high standards while acting in the best interest of the company and taking initiative to drive results. - Uphold ethical standards and being honest in all interactions. - Ability to streamline processes to focus on what matters and creates impact and acting quickly to adapt to changes. - Demonstrated ability to embrace new ideas, challenge the status quo, and seek innovative solutions while valuing diverse perspectives and treating others with respect and dignity. Compensation and Benefits: The expected salary range for this position is $167,000 – $270,000. Actual pay will be determined based on experience, qualifications, location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. We offer best-in-class benefits for our team of SpringWorkers who work with urgency on behalf of patients suffering from devastating diseases. Interested in learning more, review additional information here [Benefits](https://springworkstx.com/careers/benefits/). EEO Statement: SpringWorks maintains an EEO Policy providing for equitable opportunities for employment and conditions of employment to all employees and applicants regardless of actual or perceived sex (including pregnancy, childbirth, breastfeeding or related medical conditions), gender, gender identity or gender expression, sexual orientation, partnership status, marital status, familial status, pregnancy status, race, color, national origin, ancestry, caste, religion, religious creed, age, alienage or citizenship status, veteran status, military status, physical or mental disability, past or present history of mental disorder, medical condition, AIDS/HIV status, sickle cell or hemoglobin C trait, genetic predisposition, genetic information, protected medical leaves, victims of domestic violence, stalking, or sex offense, political affiliation and any and all other characteristics or categories protected by applicable federal, state or local laws. SpringWorks treats all employees and applicants fairly in the selection process (and in other personnel activities) by giving all employees and applicants the same opportunities for employment. SpringWorks’ Equal Employment Opportunity Policy is intended to ensure that there are no barriers that would prevent members of a protected group from a fair and equitable opportunity to be hired, promoted, or to otherwise take advantage of employment opportunities. This Equal Employment Opportunity Policy applies to all aspects of employment, including, without limitation, recruitment, hiring, placement, job assignment, promotion, termination, transfer, leaves of absence, compensation, discipline, and access to benefits and training. Any violation of this Policy will result in disciplinary action up to and including termination of employment. Privacy: Upon submission of this form I understand that SpringWorks Therapeutics is based in the United States and personal data submitted in the form will be transferred and accessed in the U.S.. Information about SpringWorks Therapeutics’ privacy practices can be found at https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fspringworkstx.com%2fprivacy-policy%2f&c=E,1,BD35FHgy1RxvzeWax2mV0qEVg3OfnWVnH9UAE_kbR4Qxe6-WmuH6GscSqesgEvL7QgHjcDXo0uWQw6MBxJlqRq-wDoY16zjPmHPK8_nUDRgAPA,,&typo=1[springworkstx.com](https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fspringworkstx.com&c=E,1,6BmxztI3ctECzNQOe0UHV03yZx9j-Yq5R4PdnIqHiqfxyIU-FpKGq0H-mC5XKvYyi0lXTCDw1loelZS00J9qTEoJQkWo0eiczLkTiNiTUDACDyt_&typo=1&ancr_add=1)). ## About SpringWorks Therapeutics ## Company Overview - **One-liner**: SpringWorks Therapeutics is a commercial-stage biopharmaceutical company dedicated to unlocking the full potential of targeted oncology for patients with rare tumors. - **Entity Type**: Public (NASDAQ: SWTX) – acquired by Merck KGaA, Darmstadt, Germany, in April 2025 for $3.9B - **Headquarters**: Stamford, Connecticut, United States - **Founded**: 2017 - **Founders**: Not publicly available (spun out from Pfizer in 2017) ## Core Business - **Primary industry/industries**: Biotechnology – targeted oncology, rare diseases - **Target customers**: B2B (healthcare providers, hospitals, academic centers) and B2C (patients, patient advocacy groups) - **Mission or purpose statement**: “Improving the lives of patients with rare tumors” by waging science with tenacity and urgency [springworkstx.com](https://springworkstx.com/who-we-are/) ## Products & Services - **OGSIVEO® (nirogacestat)**: First and only FDA- and EC-approved gamma secretase inhibitor for adults with progressing desmoid tumors. Also being studied in multiple myeloma, ovarian granulosa cell tumors, and pediatric desmoid tumors. [springworkstx.com](https://springworkstx.com/pipeline/) - **EZMEKLY® (mirdametinib)**: First and only FDA- and EC-approved MEK inhibitor for adult and pediatric patients (2 years+) with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). Also in Phase 2 for pediatric low-grade gliomas. [springworkstx.com](https://springworkstx.com/pipeline/) - **SW-682 (TEAD inhibitor)**: Novel small molecule in preclinical development for biomarker-defined solid tumors driven by Hippo pathway mutations. [springworkstx.com](https://springworkstx.com/pipeline/) - **SW-3431 (PP2A activator)**: First-in-class small molecule activator of specific PP2A complexes in preclinical development for rare uterine cancers. [springworkstx.com](https://springworkstx.com/pipeline/) ## Market Standing - **Valuation/Market Cap**: $2.3B (as of acquisition by Merck KGaA on April 28, 2025, for $3.9B) [linkedin.com](https://www.linkedin.com/company/springworks-therapeutics) - **Key Metric**: Annual Revenue $191.6M (2024) / Total Funding raised $1.015B (including Series A, B, and post-IPO equity) [linkedin.com](https://www.linkedin.com/company/springworks-therapeutics) - **Notable Investors/Partners**: Perceptive Advisors (led Series B), GSK, Janssen, Pfizer, Regeneron (collaborations), Children’s Oncology Group, St. Jude Children’s Research Hospital [springworkstx.com](https://springworkstx.com/pipeline/) - **Growth Signals**: Two approved products in both U.S. and EU; commercial-stage with $191.6M revenue; 302 employees (down 2.8% YoY due to acquisition integration); operating in 5 countries (U.S., Germany, Switzerland, Italy, UK); pipeline of 4+ programs in Phase 1/2 and preclinical [linkedin.com](https://www.linkedin.com/company/springworks-therapeutics) ## Competitive Advantages - **First-to-market in rare tumor niches**: Only approved therapy for desmoid tumors (OGSIVEO) and first approved for NF1-PN in both adults and children (EZMEKLY). - **Deep pipeline of targeted therapies** covering both rare and genetically defined cancers, with multiple collaborations with top pharma and academic centers. - **Parent company support**: Now part of Merck KGaA, providing global commercial infrastructure, R&D resources, and financial stability. - **Tenacious culture**: Emphasizes “Care Hard, Ambition Without Ego, Think Deeply Act Quickly, Good Enough is Never Enough, In It Together” – a strong, mission-driven ethos [springworkstx.com](https://springworkstx.com/careers/). ## Strategic Focus - **Continue to maximize OGSIVEO and EZMEKLY** in existing and new geographies (EU approval just granted in 2025). - **Expand pipeline into earlier-stage, biomarker-defined cancers** (Hippo mutant tumors, PP2A-driven uterine cancers) and combination therapies (BCMA-targeting agents in multiple myeloma). - **Leverage Merck KGaA’s global reach** to accelerate clinical development and commercialization of pipeline assets. - **Invest in pediatric indications** (desmoid tumors, low-grade gliomas) to address high unmet need. ## Why Work Here - **Mission-driven impact**: Directly improve lives of patients with rare tumors – “Change the lives of patients” and “Help launch groundbreaking therapies” are core promises [springworkstx.com](https://springworkstx.com/careers/). - **Culture of tenacity and collaboration**: Values include “Care Hard” and “Ambition Without Ego” – fosters a supportive, high-expectation environment. - **Diversity & inclusion**: Employee Resource Groups (ERGs) actively promote belonging; DEI is integral to the company’s DNA [springworkstx.com](https://springworkstx.com/careers/). - **Professional growth**: Stretch opportunities, mentorship from smart colleagues, and a chance to help build a company within a larger global pharma (Merck KGaA). - **Benefits**: Competitive compensation, benefits, and the chance to work on therapies that are first-in-class or best-in-class. - **Work policy**: Not explicitly stated, but the company has offices in Stamford, CT, and roles across the U.S. and Europe; likely hybrid/office for commercial and lab roles. - **Headcount**: ~302 employees; recently acquired by Merck, so stability is high but integration may bring changes. ## Sources 1. [springworkstx.com](https://springworkstx.com/) – Company overview, pipeline, news 2. [springworkstx.com](https://springworkstx.com/who-we-are/) – About Us, mission, values 3. [springworkstx.com](https://springworkstx.com/careers/) – Careers page, culture, benefits 4. [springworkstx.com](https://springworkstx.com/pipeline/) – Pipeline details, collaborations 5. [linkedin.com](https://www.linkedin.com/company/springworks-therapeutics) – Employee count, revenue, funding, market cap, acquisition details ## Other roles at SpringWorks Therapeutics - [Territory Business Manager - Detroit (OGSIVEO)](https://feeny.ai/job/territory-business-manager-detroit-ogsiveo-springworks-therapeutics-detroit-mi-f4ss3f5sq37k) — / Detroit MI, United States - [Regional Marketing Lead - NF1-PN (Southeast)](https://feeny.ai/job/regional-marketing-lead-nf1-pn-southeast-springworks-therapeutics-y6ce45r9j76g) — /, United States - [Regional Marketing Lead - NF1-PN (Northeast)](https://feeny.ai/job/regional-marketing-lead-nf1-pn-northeast-springworks-therapeutics-p3cs6dy5rrgs) — /, United States - [Territory Business Manager - San Francisco (OGSIVEO)](https://feeny.ai/job/territory-business-manager-san-francisco-ogsiveo-springworks-therapeutics-san-2t42ft4j045e) — / San Francisco CA, United States - [Territory Business Manager - Chicago (GOMEKLI)](https://feeny.ai/job/territory-business-manager-chicago-gomekli-springworks-therapeutics-chicago-jq8b1vt8329d) — / Chicago Illinois, United States - [Territory Business Manager - San Francisco (GOMEKLI)](https://feeny.ai/job/territory-business-manager-san-francisco-gomekli-springworks-therapeutics-san-yzajfm6fthtx) — / San Francisco CA, United States - [Vice President, US Marketing](https://feeny.ai/job/vice-president-us-marketing-springworks-therapeutics-boston-ma-qzb38343hnwm) — / Boston MA, United States - [Territory Business Manager - Milwaukee (GOMEKLI)](https://feeny.ai/job/territory-business-manager-milwaukee-gomekli-springworks-therapeutics-milwaukee-b49p3n8mz7q6) — / Milwaukee Wisconsin, United States - [Executive Director, Brand Lead U.S. NF1-PN Marketing](https://feeny.ai/job/executive-director-brand-lead-u-s-nf1-pn-marketing-springworks-therapeutics-2zq2kw3b3prr) — / Boston MA, United States - [Senior Director, Digital & Omnichannel Strategy](https://feeny.ai/job/senior-director-digital-omnichannel-strategy-springworks-therapeutics-boston-ma-jm6szee7haev) — / Boston MA, United States